Tykerb & Letrozole (lapatinib)

pCPA File Number: 20748
Negotiation Status:
Negotiations were not pursued
Indication(s):
early breast cancer/metastatic breast cancer/metastatic gastric cancer
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: